Compounds of formula (I):
##STR1##
wherein:
- X is a group of formula (A) or (B):
##STR2##
and R1, R2, R3, R4, n, x, y and z
are as defined within are described.
Processes for their preparation and their use in the treatment of disorders
mediated by the neuropeptide Y5 receptor in a warm-blooded animal, such as a human
being are also described.
|
|
|
